Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
about
Neoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy?Expression of hypoxia-inducible protein 2 in renal cell carcinoma: A promising candidate for molecular targeting therapySurgical treatment options and management strategies of metastatic renal cell carcinoma to the lumbar spinal nerve roots.A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma.
P2860
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@en
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@nl
type
label
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@en
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@nl
prefLabel
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@en
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@nl
P2860
P1476
Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
@en
P2093
Yoichi Mizutani
P2860
P304
P356
10.1111/J.1442-2042.2009.02277.X
P577
2009-03-03T00:00:00Z